239 related articles for article (PubMed ID: 9742126)
1. ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.
Pinkas-Kramarski R; Shelly M; Guarino BC; Wang LM; Lyass L; Alroy I; Alimandi M; Kuo A; Moyer JD; Lavi S; Eisenstein M; Ratzkin BJ; Seger R; Bacus SS; Pierce JH; Andrews GC; Yarden Y
Mol Cell Biol; 1998 Oct; 18(10):6090-101. PubMed ID: 9742126
[TBL] [Abstract][Full Text] [Related]
2. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor.
Tzahar E; Waterman H; Chen X; Levkowitz G; Karunagaran D; Lavi S; Ratzkin BJ; Yarden Y
Mol Cell Biol; 1996 Oct; 16(10):5276-87. PubMed ID: 8816440
[TBL] [Abstract][Full Text] [Related]
3. Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3.
Vartanian T; Goodearl A; Viehöver A; Fischbach G
J Cell Biol; 1997 Apr; 137(1):211-20. PubMed ID: 9105049
[TBL] [Abstract][Full Text] [Related]
4. Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations.
Pinkas-Kramarski R; Shelly M; Glathe S; Ratzkin BJ; Yarden Y
J Biol Chem; 1996 Aug; 271(32):19029-32. PubMed ID: 8702572
[TBL] [Abstract][Full Text] [Related]
5. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
6. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
7. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms.
Tzahar E; Levkowitz G; Karunagaran D; Yi L; Peles E; Lavi S; Chang D; Liu N; Yayon A; Wen D
J Biol Chem; 1994 Oct; 269(40):25226-33. PubMed ID: 7929212
[TBL] [Abstract][Full Text] [Related]
8. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.
Beerli RR; Graus-Porta D; Woods-Cook K; Chen X; Yarden Y; Hynes NE
Mol Cell Biol; 1995 Dec; 15(12):6496-505. PubMed ID: 8524214
[TBL] [Abstract][Full Text] [Related]
9. Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration.
Carroll SL; Miller ML; Frohnert PW; Kim SS; Corbett JA
J Neurosci; 1997 Mar; 17(5):1642-59. PubMed ID: 9030624
[TBL] [Abstract][Full Text] [Related]
10. Heregulins and the ErbB-2/3/4 receptors in gliomas.
Westphal M; Meima L; Szonyi E; Lofgren J; Meissner H; Hamel W; Nikolics K; Sliwkowski MX
J Neurooncol; 1997 Dec; 35(3):335-46. PubMed ID: 9440030
[TBL] [Abstract][Full Text] [Related]
11. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
Karunagaran D; Tzahar E; Beerli RR; Chen X; Graus-Porta D; Ratzkin BJ; Seger R; Hynes NE; Yarden Y
EMBO J; 1996 Jan; 15(2):254-64. PubMed ID: 8617201
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities.
Beerli RR; Hynes NE
J Biol Chem; 1996 Mar; 271(11):6071-6. PubMed ID: 8626392
[TBL] [Abstract][Full Text] [Related]
13. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases.
Carraway KL; Weber JL; Unger MJ; Ledesma J; Yu N; Gassmann M; Lai C
Nature; 1997 May; 387(6632):512-6. PubMed ID: 9168115
[TBL] [Abstract][Full Text] [Related]
14. An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4.
Chen X; Levkowitz G; Tzahar E; Karunagaran D; Lavi S; Ben-Baruch N; Leitner O; Ratzkin BJ; Bacus SS; Yarden Y
J Biol Chem; 1996 Mar; 271(13):7620-9. PubMed ID: 8631797
[TBL] [Abstract][Full Text] [Related]
15. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling.
Graus-Porta D; Beerli RR; Hynes NE
Mol Cell Biol; 1995 Mar; 15(3):1182-91. PubMed ID: 7532277
[TBL] [Abstract][Full Text] [Related]
16. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF
J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723
[TBL] [Abstract][Full Text] [Related]
17. Ligands for ErbB-family receptors encoded by a neuregulin-like gene.
Chang H; Riese DJ; Gilbert W; Stern DF; McMahan UJ
Nature; 1997 May; 387(6632):509-12. PubMed ID: 9168114
[TBL] [Abstract][Full Text] [Related]
18. Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2.
Zhang K; Sun J; Liu N; Wen D; Chang D; Thomason A; Yoshinaga SK
J Biol Chem; 1996 Feb; 271(7):3884-90. PubMed ID: 8632008
[TBL] [Abstract][Full Text] [Related]
19. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.
Marte BM; Jeschke M; Graus-Porta D; Taverna D; Hofer P; Groner B; Yarden Y; Hynes NE
Mol Endocrinol; 1995 Jan; 9(1):14-23. PubMed ID: 7760847
[TBL] [Abstract][Full Text] [Related]
20. Bivalence of EGF-like ligands drives the ErbB signaling network.
Tzahar E; Pinkas-Kramarski R; Moyer JD; Klapper LN; Alroy I; Levkowitz G; Shelly M; Henis S; Eisenstein M; Ratzkin BJ; Sela M; Andrews GC; Yarden Y
EMBO J; 1997 Aug; 16(16):4938-50. PubMed ID: 9305636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
